Does Rallies track congressional trades in GNPX?

Yes. Rallies tracks politician and congressional stock disclosures for GNPX, including reported purchases, sales, dates, owners, and trade amounts when available.

Is GNPX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GNPX. It does not provide personalized investment advice.

GNPX (Genprex, Inc. Common Stock) Stock Analysis - Politician Trades

Genprex, Inc. Common Stock (GNPX) is a publicly traded Healthcare sector company. As of May 20, 2026, GNPX trades at $0.79 with a market cap of $8.39M and a P/E ratio of -0.04. GNPX moved -1.47% today. Year to date, GNPX is -56.12%; over the trailing twelve months it is -94.52%. Its 52-week range spans $0.74 to $198.50. Rallies surfaces GNPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded GNPX stock?

Recent politician trading activity in GNPX includes disclosures from Tim Moore, Tim Moore, and Tim Moore. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

GNPX Key Metrics

Key financial metrics for GNPX
Metric	Value
Price	$0.79
Market Cap	$8.39M
P/E Ratio	-0.04
EPS	$-17.40
Dividend Yield	0.00%
52-Week High	$198.50
52-Week Low	$0.74
Volume	211.51K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-16.23M
Gross Margin	0.00%

Congressional Trades in GNPX

Tim Moore purchase GNPX on Feb 5, 2026 (amount: $15.00K).
Tim Moore purchase GNPX on Dec 18, 2025 (amount: $15.00K).
Tim Moore purchase GNPX on Nov 7, 2025 (amount: $15.00K).

Latest GNPX News

Genprex Partners with MD Anderson to Study TROP2, PTEN Biomarkers for Reqorsa Trials — Apr 21, 2026
Genprex Preclinical Data Show 79% Tumor Shrinkage and Biomarker Insight for Lung Cancer — Apr 20, 2026
Genprex Stock Drops 9.5% After Congressman Moore Buys $1,000–$15,000 Stake — Feb 26, 2026
Genprex Secures Japanese, European Patents for REQORSA-Immunotherapy Combinations — Feb 23, 2026

Recent GNPX Insider Trades

LONGNECKER BRENT M sold 8 (~$9.84) on Apr 14, 2026.
LONGNECKER BRENT M sold 10 (~$12.3) on Apr 14, 2026.
Varner John Rodney bought 19.00K (~$20.05K) on Apr 21, 2023.

GNPX Analyst Consensus

GNPX analyst coverage data. Average price target: $0.00.

Common questions about GNPX

Which politicians traded GNPX stock?: Recent politician trading activity in GNPX includes disclosures from Tim Moore, Tim Moore, and Tim Moore. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in GNPX?: Yes. Rallies tracks politician and congressional stock disclosures for GNPX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is GNPX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GNPX. It does not provide personalized investment advice.